Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts
Clinical trial NCT00058812 · COMPLETED
Trial details
- NCT number
- NCT00058812
- Sponsor
- Baylor College of Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1993-05-01
- Primary completion
- 2014-07-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.